Re: Bromocriptine and pregnancy
From: Robert J. Carpenter, Jr. MD (zygote@icsi.net)
Thu Sep 22 16:16:44 2005
I am unaware of any body with adverse effect and have used it many times in patients
with adenomas all of which was previously symptomatic. They grow during pregnancy
so continuation is appropriate.
If I have someone who is using it, I do not stop it when I either consult or assume
primary care.
Bob
On 21 Sep 2005 at 10:57, art fougner, md wrote:
> >From Creasy & Resnick 4th ed ...
>
> Management of Patients harboring prolactinomas during gestation
>
> Microadenoma -
>
> asymptomatic patient - STOP bromocryptine
> Routine OB care with evaluation for symptoms
> of tumor expansion
> visual fields per trimester
>
> symptomatic patient - check visual fields
> serum prolactin
> MRI
> initiate bromocryptine w or w/o dexamthasone for
> visual complications
> surgery if unresponsive to medical therapy
>
> Macroadenoma -
>
> asymptomatic - STOP bromocryptine
> Monthly evaluation for symptoms of tumor expansion
> Monthly visual fields
>
> symptomatic - as for Microadenoma
>
> hope this helps
>
> art
>
> At Wed, 21 Sep 2005, Elrod Darryl G MAJ 48 MDOS/SGOBO wrote:
> >
> >I'm getting conflicting recommendations regarding the continued use
> >of bromocriptine once someone becomes pregnant. Up to Date says to
> >stop it once pregnancy is confirmed and Williams doesn't really say,
> >but says that 6000 women have taken it without adverse affects to the
> >pregnancy.
> >
> >Does anyone have any better guidelines than these?
> >
> >Thanks,
> >
> >Glen
> >
> >//SIGNED//
> >
> >D. Glen Elrod, Maj., USAF, MC
> >
> >Obstetrician/Gynecologist
> >
> >Chief of Obstetrics
> >
> >48 MDOS/SGOBO
> >
> >RAF Lakenheath, England
> >
> >Telephone DSN: 314-226-8130
> >
> > Comm: +44 (0) 1638 52 8130
> >
> >Notice of Confidentiality
> >Under the Privacy Act of 1974, you must safeguard all information
> >reflected on this e-mail and, if applicable, all attachments.
> >Disclosure of information is IAW AFI 33-119, AFI 33-127, AFI 37-131,
> >AFI 37-132, AFI 33-219, and PL 93-579" This e-mail message including
> >any attachments is for the sole use of the intended recipient(s) and
> >may contain confidential and privileged information. Any unauthorized
> >review, use, disclosure or distribution is prohibited. If you are
> >not the intended recipient, please contact the sender by reply e-mail
> >and destroy all copies of the original message. Any questions
> >pertaining to disclosure should be directed to the privacy officer.
>
> --
> art fougner, md
>
> "If you don't know where you are going, you will wind up somewhere
> else."
> Lawrence Peter Berra
>
--
Robert J. Carpenter, Jr. MD
6624 Fannin, #2720
St. Luke's Medical Tower
Houston,TX 77030-2339
713-795-4600
|
|
